A detailed history of Tower Research Capital LLC (Trc) transactions in Lifevantage Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 909 shares of LFVN stock, worth $15,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
909
Previous 500 81.8%
Holding current value
$15,098
Previous $3,000 233.33%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.51 - $13.01 $2,253 - $5,321
409 Added 81.8%
909 $10,000
Q2 2024

Aug 13, 2024

BUY
$5.75 - $7.95 $2,725 - $3,768
474 Added 1823.08%
500 $3,000
Q1 2024

May 15, 2024

SELL
$5.31 - $7.01 $3,032 - $4,002
-571 Reduced 95.64%
26 $0
Q4 2023

Feb 13, 2024

BUY
$4.38 - $8.25 $2,614 - $4,925
597 New
597 $3,000
Q2 2023

Aug 14, 2023

SELL
$3.04 - $5.5 $22,140 - $40,056
-7,283 Reduced 65.15%
3,895 $16,000
Q1 2023

May 09, 2023

SELL
$3.26 - $4.0 $14,611 - $17,928
-4,482 Reduced 28.62%
11,178 $40,000
Q4 2022

Feb 10, 2023

BUY
$3.63 - $4.03 $15,601 - $17,320
4,298 Added 37.83%
15,660 $58,000
Q3 2022

Nov 10, 2022

BUY
$3.48 - $4.51 $21,360 - $27,682
6,138 Added 117.5%
11,362 $42,000
Q2 2022

Aug 15, 2022

BUY
$3.82 - $4.89 $19,061 - $24,401
4,990 Added 2132.48%
5,224 $23,000
Q1 2022

May 12, 2022

SELL
$4.74 - $6.68 $1,858 - $2,618
-392 Reduced 62.62%
234 $1,000
Q4 2021

Feb 14, 2022

SELL
$6.15 - $7.68 $5,627 - $7,027
-915 Reduced 59.38%
626 $4,000
Q3 2021

Nov 15, 2021

SELL
$6.5 - $8.38 $9,782 - $12,611
-1,505 Reduced 49.41%
1,541 $10,000
Q2 2021

Aug 16, 2021

BUY
$6.9 - $9.59 $7,900 - $10,980
1,145 Added 60.23%
3,046 $23,000
Q1 2021

May 17, 2021

SELL
$8.58 - $10.21 $30,390 - $36,163
-3,542 Reduced 65.07%
1,901 $17,000
Q4 2020

Feb 16, 2021

SELL
$9.32 - $13.4 $100,600 - $144,639
-10,794 Reduced 66.48%
5,443 $50,000
Q3 2020

Nov 16, 2020

BUY
$12.07 - $15.31 $158,949 - $201,617
13,169 Added 429.24%
16,237 $196,000
Q2 2020

Aug 13, 2020

BUY
$10.25 - $16.54 $30,422 - $49,090
2,968 Added 2968.0%
3,068 $41,000
Q1 2020

May 15, 2020

SELL
$7.91 - $16.96 $21,293 - $45,656
-2,692 Reduced 96.42%
100 $1,000
Q4 2019

Feb 07, 2020

BUY
$13.48 - $15.86 $5,041 - $5,931
374 Added 15.47%
2,792 $43,000
Q3 2019

Nov 05, 2019

BUY
$10.8 - $14.6 $3,855 - $5,212
357 Added 17.32%
2,418 $33,000
Q2 2019

Aug 13, 2019

BUY
$10.68 - $14.55 $5,671 - $7,726
531 Added 34.71%
2,061 $26,000
Q1 2019

May 14, 2019

BUY
$12.54 - $16.12 $9,216 - $11,848
735 Added 92.45%
1,530 $22,000
Q4 2018

Feb 14, 2019

BUY
$10.06 - $14.87 $4,527 - $6,691
450 Added 130.43%
795 $10,000
Q3 2018

Nov 13, 2018

SELL
$6.33 - $13.02 $102,052 - $209,908
-16,122 Reduced 97.9%
345 $4,000
Q2 2018

Aug 15, 2018

BUY
$3.35 - $6.42 $17,034 - $32,645
5,085 Added 44.68%
16,467 $105,000
Q1 2018

May 15, 2018

BUY
$3.61 - $4.91 $11,396 - $15,500
3,157 Added 38.38%
11,382 $41,000
Q4 2017

Feb 09, 2018

BUY
$4.43 - $6.43 $36,436 - $52,886
8,225
8,225 $39,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $209M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.